Clinical Trials
10 trialsNCT05105100 2026-04-06
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
Completed
NCT07327489 2026-01-08
ELEPHAS-05
Elephas
Recruiting
NCT04136470 2020-08-10
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
Unknown
NCT04493723 2020-07-30
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The Christie NHS Foundation Trust
Recruiting
NCT02938728 2016-10-25
PREDIMEL
Assistance Publique - Hôpitaux de Paris
Unknown
NCT00900302 2016-02-10
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Completed
NCT00099112 2015-04-30
Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II
National Cancer Institute (NCI)
Completed
NCT01801670 2015-01-27
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Boston University
Withdrawn
NCT01482260 2012-11-06
Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma
Ruhr University of Bochum
Completed
NCT00430053 2012-03-15
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Completed